•  
  •  
 

Henry Ford Hospital Medical Journal

Volume 35, Number 2 (1987) Second International Workshop on MEN-2

Articles

PDF

Impact of Prospective Screening for Multiple Endocrine Neoplasia Type 2
Robert F. Gagel, Armen H. Tashjian Jr., Tim Cummings, Nick Papathanasopoulos, and Seymour Reichlin

PDF

MEN-2 Syndrome: The Value of Screening and Central Registration; A Study of Six Kindreds in The Netherlands
H. F. A. Vasen, A. C. Nieuwenhuijzen Kruseman, A. M. J. Moers, C. J. M. Lips, E. K. M. Beukers, W. M. Wiersinga, and R. A. Geerdink

PDF

Characteristics of a Family with the MEN-2A Syndrome
Harm R. Haak and Arie C. Nieuwenhuijzen Kruseman

PDF

Multiple Endocrine Neoplasia Type 2A: A Northern Ireland and Australian Family
David R. Hadden, Fergus O'Reilly, Laurence Kennedy, and Colin Russell

PDF

Screening for Early Asymptomatic Pheochromocytoma in MEN-2
Margareta Telenius-Berg, Bertel Berg, Bertil Hamberger, and Sten Tibblin

PDF

Calcitonin Gene Peptides: The Diagnostic Value of Measurement in Medullary Thyroid Carcinoma
Samia I. Girgis, Catherine Lynch, Carmel J. Hillyard, John C. Stevenson, Patricia A. Hill, David W. R. MacDonald, and Iain MacIntyre

PDF

Clinical Value of Calcitonin and Carcinoembryonic Antigen Doubling Times in Medullary Thyroid Carcinoma
Charles E. Jackson, Robert A. Norum, Gary B. Talpos, Carolyn S. Feldkamp, and Armen H. Tashjian Jr.

PDF

Importance of Ultrasound Examination for the Follow-up of Medullary Thyroid Carcinoma: Comparison with Other Localization Methods
Karin Frank, Friedhelm Raue, Dorothea Lorenz, Christian Herfarth, and Reinhard Ziegler

PDF

Subtotal Adrenalectomy in Multiple Endocrine Neoplasia Type 2
Bertil Hamberger, Margareta Telenius-Berg, Bjorn Cedermark, Staffan Grondal, Bengt-Goran Hansson, and Sigbritt Werner

PDF

A Two-Site Immunoradiometric Assay for Serum Calcitonin Using Monoclonal Anti-Peptide Antibodies
Philippe Motte, Malika Ait-Abdellah, Pascal Vauzelle, Paule Gardet, Claude Bohuon, and Dominique Bellet

PDF

Thyroid C-Cell Hyperplasia and Micronodules in Close Relatives of MEN-2 A Patients: Pitfalls in Early Diagnosis and Reevaluation of Criteria for Surgery
Cees J. M. Lips, John R. Leo, Marianne J. H. Berends, Werner H. Minder, A. P. Roeland Blok, Rolf A. Geerdink, Wil H. L. Hackeng, Jan M. M. Roelofs, Hans F. A. Vasen, and Jan K. Vette

PDF

Immunohistochemistry in Medullary Thyroid Carcinoma: Prognosis and Distinction Between Hereditary and Sporadic Tumors
B. Franc, B. Caillou, A. M. Carrier, N. Dutrieux-Berger, J. Floquet, M. Houcke, E. Justrabo, F. Lange, A. Pages, C. Rigaud, A. Schwartz, M. Viennet, and M. F. Lebodic

PDF

Plasma and Tumor Levels of Somatostatin (SRIF) and Somatostatin Immunochemistry in Medullary Thyroid Carcinoma: Apparently Discrepant Preliminary Results
B. Franc, J. A. Chayvialle, E. Modigliani, C. Calmettes, B. Caillou, N. Dutrieux-Berger, C. Houdent, and M. Kujas

PDF

Studies of Multiple Endocrine Neoplasia Type 2A Syndrome: Linkage Analyses and Comparison of Constitutional and Tumor Genotypes
Hideo Tateishi, Shin-ichiro Takai, Isamu Nishisho, Tetsuro Miki, Kazuyoshi Motomura, Makoto Okazaki, Akira Miyauchi, Tatsuro Ikeuchi, Kohtaro Yamamoto, Tatsuo Hattori, Yuichi Kumahara, Hideo Matsumoto, Tasuko Honjo, and Takesada Mori

PDF

Application of Minisatellite DNA Probes to Linkage in MEN-2
Bruce A. J. Ponder, Alec J. Jeffreys, Nicola E. Hartley, Clare Carter, Douglas F. Easton, Hakan Telenius, and Margareta Telenius-Berg

PDF

One Large Kindred Excludes a Locus for Multiple Endocrine Neoplasia Type 2A from about 25% of the Human Autosomal Genetic Map
Andrew J. Pakstis, Judith R. Kidd, Carmela M. Castiglione, Beth A. Pletcher, Patricia D. Murphy, Lindsay A. Farrer, Myron Genel, and Kenneth K. Kidd

Henry Ford Hospital Medical Journal Cover